Corporate Whistleblower Now Urges a Doctor with Proof a Pharma Company is Illegally Using Speaker Fees to Get Physicians to Prescribe More Drugs to Call Them About Possible Rewards
WASHINGTON, Jan. 11, 2017 /PRNewswire/ -- The Corporate Whistleblower says, "We are urging a medical doctor or pharmaceutical company insider to call us anytime at 866-714-6466 if they possess proof a drug company is essentially bribing physicians to prescribe more drugs. The pay-off could range from free meals, expensive vacation's/conferences or speaker fees. We are specifically targeting drug companies engaged in the following types of practices:
- "Drug or medical device companies bribing physicians in any way to over prescribe their products."
- "Drug companies promoting off-labeling their pharmaceutical products to medical doctors." http://CorporateWhistleblower.Com
Recently the Department of Justice received a $38 million settlement to resolve allegations that a pharmaceutical company violated the Anti-Kickback Statute, which prohibits the payment of remuneration to induce referrals of items or services covered by federal health care programs, by providing payments and meals to certain physicians. The DOJ alleged the free meals were provided as an inducement for physicians to prescribe more pharmaceutical products.
In this instance the whistleblower will receive approximately $7.8 million.
The Corporate Whistleblower is saying, "We are inviting a physician to call us anytime at 866-714-6466 if they possess proof a pharmaceutical company's reps are attempting to bribe physicians into prescribing more drugs-especially if we are talking about Medicare patients, and or if drug reps are promoting off-labeling. One unique feature we can offer a medical doctor with this kind of information is we will attempt to build out the wrongdoing to potentially dramatically expand the potential whistleblower reward. Please don't sit on a potentially winning lotto ticket if you possess this type of information." http://CorporateWhistleblower.Com
For a recent news article related to drug companies making payments to medical doctors please refer to an NPR article related to this topic:
http://www.npr.org/sections/health-shots/2016/03/17/470679452/drug-company-payments-mirror-doctors-brand-name-prescribing
Simple rules for a whistleblower from the Corporate Whistleblower: Do not go to the government first if you want to become a whistleblower: The Corporate Whistleblower Center says, "Major whistleblowers frequently go to the government thinking they will help. It's a huge mistake. Do not go to the news media with your whistleblower information either. Any type of public revelation of a whistleblower's information could destroy the prospect for a reward. Do not try to force a healthcare company or individual to come clean on kickbacks or Stark violations. Come to us first, tell us what type of information you have, and if we think it's sufficient, we will help find the right law firms to assist in advancing your information."
The Corporate Whistleblower is the premier advocate for whistleblowers in the United States. Unlike any group in the US, they assist potential whistleblowers with packaging their information and providing the whistleblower with access to the most accomplished whistleblower attorneys in the nation. For more information a potential whistleblowers in any state can contact the Corporate Whistleblower Center anytime at 866-714-6466 or visit http://CorporateWhistleblower.Com.
For more information about a recent Department of Justice settlement related to a pharmaceutical company paying off physicians please refer to the December 2016 DOJ press release on the topic
https://www.justice.gov/opa/pr/forest-laboratories-and-forest-pharmaceuticals-pay-38-million-resolve-kickback-allegations
Media contact:
Thomas Martin
[email protected]
866-714-6466
SOURCE Corporate Whistleblower
Related Links
http://CorporateWhistleblower.Com
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article